Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the monthly archives: August, 2017

We are pleased to present below all posts archived in 'August, 2017'. If you still can't find what you are looking for, try using the search box.

Speculative 110,000 sq ft office and laboratory Development reaches key milestone on at Milton Park, Oxfordshire

Construction work at the £24m Park Drive East development at Milton Park being undertaken by MEPC has reached the half way milestone

Read the rest of entry »

Novartis gene therapy approval signals new cancer treatment era

Novartis AG won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.

Read the rest of entry »

Gilead buys into CAR-T with $11.9bn deal for Kite

Gilead Sciences is buying Kite Pharma in a deal worth $11.9 billion, securing itself access to the latter’s experimental CAR-T therapy axicabtagene ciloleucel and wider cancer pipeline.

Read the rest of entry »

The Midlands Engine Investment Fund (MEIF) Debt Funds (including Small Business Loans) were officially launched in August 2017, with further Equity Funds being released in due course.

The Midlands Engine Investment Fund aims to boost the region’s economy and supporting the growth ambitions of the 780,000 smaller businesses within the region. It is part funded by the European Regional Development Fund.

Read the rest of entry »

Industry proposals to help the UK become a world leader in life sciences are set to be unveiled.

Professor Sir John Bell, who led a review into the £64 billion life sciences industry, will use a speech at the University of Birmingham's Institute of Translational Medicine on Wednesday to outline its findings.

Read the rest of entry »

Organoid Culture & Genetic Manipulation

AMSBIO announces its sponsorship of the 'Discovering Organoids: Establishment, Culture & Manipulation’ hands-on training course* due to be hosted at Homerton College, University of Cambridge, UK, on 11th and 12th September 2017.


Read the rest of entry »

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures

Merck Ventures Joins Investment Syndicate and the Board of Macrophage

Read the rest of entry »

Oxford Immunotec Global PLC Announces Agreement to Sell 2,500,000 Ordinary Shares

Oxford Immunotec intends to use the net proceeds from the offering for working capital and general corporate purposes.

Read the rest of entry »

China- Visit by the Future Health Industry Entrepreneurs Association

The Department for International Trade Life Sciences Organisation (DIT LSO) and the China Britain Business Council (CBBC) will be hosting a delegation from the Future Health Industry Entrepreneurs Association (FHA) from China on the morning of Tue 5 Sep.

Read the rest of entry »

ELISA-like Assay for Hyaluronic Acid

AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.


Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.